Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/paracetamol versus NSAIDs and corticosteroids for chronic pain in rheumatoid arthritis
2006-004062-13Phase 3Terminated
- Sponsor
- AUSL Romagna
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxycodone and acetaminophen in rheumatoid arthritis (RA) (2 arms), sponsored by AUSL Romagna. Primary endpoints: Primary efficacy and safety endpoint, Phase II primary objective and 1 more. Started Aug 2006; status: terminated.
02
Drugs
oxycodoneacetaminophen
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-004062-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004062-13.